WO2017123020A2 - 구강용 제제 - Google Patents
구강용 제제 Download PDFInfo
- Publication number
- WO2017123020A2 WO2017123020A2 PCT/KR2017/000409 KR2017000409W WO2017123020A2 WO 2017123020 A2 WO2017123020 A2 WO 2017123020A2 KR 2017000409 W KR2017000409 W KR 2017000409W WO 2017123020 A2 WO2017123020 A2 WO 2017123020A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tooth
- formulation
- alginate
- polymer
- preparation
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/055—Phenols the aromatic ring being substituted by halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/16—Fluorine compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Definitions
- the present invention relates to a mouse band that can be attached to the teeth or the periphery of the mouth band to deliver the active ingredient into the oral cavity, and more specifically, the present invention provides excellent adhesion and secures sufficient time for attachment of the mouse to effectively deliver the active ingredient into the oral cavity. It's about the band.
- Paste formulations such as toothpaste
- Paste formulations have insufficient viscosity and high solubility, making it difficult to provide sufficient contact time to the target site, and mouse trays intended for intraoral drug delivery have a high foreign body feel and local drug delivery is difficult due to their shape characteristics.
- the patch or strip form has a disadvantage in that it is difficult to deliver sufficient active ingredients, and the flexibility is poor, and it is difficult to close the tooth gap, the gum and the tooth boundary area.
- the present invention seeks to provide a formulation in a form that can be modified before use and that can be well adhered between the tooth gap or the tooth and gum.
- the present invention is to provide a new type of formulation for oral cavity that can be used comfortably, yet smooth and flexible, do not flow down, and to ensure sufficient contact time with the target site.
- the slime hydrogel formulation may be achieved by a synthetic silica or alginate compound.
- the hydrogen bonding properties of the alginate compounds affect the formation of the slime hydrogel, it has been confirmed that it can exhibit an excellent effect in achieving the thixotropy properties of the slime hydrogel, but the present invention is not limited to this theory.
- the alginate compound may be included in an amount of 0.1% to 20% by weight based on the dry weight of the formulation, preferably 5% by weight or less, more preferably 2% by weight or less, and most preferably 0.5% by weight or less. Hydrogels are preferred because they can be formed uniformly.
- the alginate compound may comprise calcium alginate, potassium alginate, sodium alginate, triethanolamine alginate, or mixtures thereof.
- the active ingredient may include, for example, a tooth whitening component, a tooth decay prevention component including a fluorine ion source, a tartar formation inhibiting component, an anti-inflammatory component, an antibacterial component, other vitamins, a mineral component, and the like.
- astringent may include amelioration and symptomatic ingredients.
- the preparation of the present invention may have a form such as dough or clay, and may be applied to the teeth or the area around the teeth in the form of an ointment.
- the preparation may be used in two-part form, and may be used in three-part form as necessary.
- a agent containing a phase change compound can be used in combination with a second agent comprising a polymer, water, an active ingredient, and other components that may be included in the formulation to control the rate of the phase transfer reaction
- a first agent containing a phase transfer compound comprising a polymer for controlling the rate of the phase transfer reaction
- a mixture of three agents including water, the active ingredient, and other ingredients that may be included in the formulation.
- the inventors of the present invention have studied a drug delivery system capable of delivering an active ingredient into the oral cavity, and have come up with a new type of drug delivery system and a new method of delivering the active ingredient into the oral cavity using such a system. .
- the formulation may further comprise a backing film as needed when attached to a tooth or periphery.
- the support layer may also serve to prevent this, because when the preparation time according to an embodiment of the present invention is long, it may be buried in unwanted areas such as gums.
- the support layer may include a water-insoluble polymer generally used in oral films, for example polyethylene (PE), polypyrophyllene (PP), ethylene vinyl acetate (EVA), cellulose acetate phthalate, shellac (Shellac) , Polyvinyl acetate, ethyl cellulose, poly methyl methacrylate, methacryloyl ethyl betaine / methacrylate copolymer (Yukaformer: Mitsubishi, methacryloylethyl betain / methacrylate copolymer), methacrylic acid copolymer Eudragit L 100, Eudragit L 12,5, Eudragit L 100-55, Eudragit L 30D-55), aminoalkyl methacrylate
- the present invention can be easily removed by brushing at the time when the drug of the formulation is released and removed.
- the contact time between the drug reaching site and the preparation of the present invention can be sufficiently secured by flowing down after dilution or not diluted by saliva.
- FIG. 2 shows the change in hardness of the formulation identified after 1 minute by mixing the formulation.
- the unit of the vertical axis was represented by g.
- Figure 2 it can be seen that the hardness increases more quickly from immediately after mixing the formulation to 1 minute in the case of the embodiment, and after 1 minute the hardness has a larger value than the comparative examples.
- 1g of the PET sheet was taken and placed in a vertical 1cm * 1cm, and then put another PET sheet on it, and compared by measuring the length that can be expanded to the maximum without tearing or puncturing by pressing with a finger.
- Evaluation method The hardness of the comparative example and the Example was measured by the Texture Analyzer.
- a feeling test was conducted using the formulation having the composition according to Table 8. Immediately before use, the first and second agents were mixed, and then a mixture thereof was applied to the support layer. Attached to the desired area using a support layer and then pressed with a finger to be in close contact. Although it is not necessary to remove the support layer, in this experiment, the support layer was removed two minutes after the attachment. Remove after 10 minutes of attachment time.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (29)
- 치아 또는 치아 주변부 부착용 제제에 있어서,상기 마우스밴드는 합성 실리카 또는 알지네이트(alginate) 화합물을 포함하는 슬라임 하이드로겔(slime hydrogel)을 포함하는 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제1항에 있어서, 상기 합성실리카는 실리카 분말, 흄드 실리카, 침전실리카, 콜로이드 실리카, 에어로겔, 실리카졸 중에서 선택된 어느 하나 이상인 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제1항에 있어서, 상기 알지네이트 화합물은 칼슘 알지네이트, 포타슘 알지네이트, 나트륨 알지네이트, 트리에탄올아민 알지네이트 또는 이의 혼합물인 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제1항에 있어서, 상기 알지네이트 화합물은 제제 총 중량 대비 0.1 중량% 내지 20 중량% 포함되는 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제1항에 있어서, 상기 하이드로겔은 폴리비닐알코올(PVA) 및 상기 폴리비닐알코올의 -OH기와 가교결합을 형성하는 염을 포함하는 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제5항에 있어서, 상기 폴리비닐알코올의 -OH기와 가교결합을 형성하는 염은 보레이트염(borate), 포스페이트염(phosphate) 또는 이의 혼합물인 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제1항에 있어서, 상기 제제는 구강 내 전달을 목적으로 하는 약효 성분을 포함하는 것을 특징으로 하는 제제.
- 구강 내 전달을 위한 약효성분을 포함하고,상전이 화합물; 및 상전이 속도를 조절하는 고분자를 포함하는, 치아 또는 치아 주변부 부착용 구강 제제.
- 제8항에 있어서, 상기 상전이 화합물은 카라기난(carrageenan), 펙틴(pectin), 자일로글루칸(xyloglucan), 젤란검(gellan gum), 암모늄 알지네이트(ammonium alginate), 마그네슘 알지네이트(magnesium alginate), 포타슘 알지네이트(potassium alginate), 소듐 알지네이트(sodium alginate), 리튬 알지네이트(lithium alginate), 키토산(chitosan), 폴리락트산(poly(D,L-lactic acid)), 폴리락타이드-코-클리코라이드(poly(DL-lactide-co-glycolide)), 폴리-카프로락톤(poly-caprolactone), 폴리아크릴산(polyacrylic acid(carbopol)), 폴리비닐아세탈 디에틸 아미노아세테이트(polyvinylacetal diethyl aminoacetate (AEA)), 하이드록시프로필메틸 셀룰로오스(hydroxypropylmethyl cellulose), 폴리(메타아크릴산)-폴리(에틸렌 글리콜)(poly(methacrylic acid)-poly(ethylene glycol)), 폴리(D,L-락타이드)-블록-폴리(에틸렌 글리콜)-블록-폴리(D,L-락타이드)(poly(D,L-lactide)-block-poly(ethylene glycol)-block-poly(D,L-lactide)), PEG-올리고글라이콜릴-아크릴레이트(PEG-oligoglycolyl-acrylate), 폴리(N-이소프로필 아크릴아마이드(poly(N-isopropyl acrylamide)), 수크로스 아세테이트 이소뷰티레이트(sucrose acetate isobutyrate), 폴리비닐 알코올(polyvinyl alcohol), 폴리비닐아세테이트(polyvinyl acetate), 글리세릴 모노올레이트, 글리세릴 모노리놀레이트(glyceryl monolinoleate), 글리세릴 모노아라키도네이트 (glyceryl monoarachidonate), 글리세릴 모노스테아레이트 (glyceryl monostearate) 또는 이들의 혼합물인 것을 특징으로 하는 제제.
- 제8항에 있어서, 상기 상전이 화합물은 암모늄 알지네이트(ammonium alginate), 마그네슘 알지네이트(magnesium alginate), 포타슘 알지네이트(potassium alginate), 소듐 알지네이트(sodium alginate), 리튬 알지네이트(lithium alginate) 또는 이의 혼합물인 것을 특징으로 하는 제제.
- 제8항에 있어서, 상기 상전이 속도를 조절하는 고분자는 수용성이며, 카르복시기 (carboxyl)를 작용기로 포함하는 것을 특징으로 하는, 제제.
- 제11항에 있어서, 상기 상전이 속도를 조절하는 고분자는 폴리 아크릴산, 폴리 아크릴산 나트륨, 카보머, 카보폴, 아크릴레이트 코폴리머, 폴리 쿼터니움-39, 메틸 비닐 에테르 및 말레산 무수물의 공중합체(PVM/MA copolymer)로 이루어진 군에서 선택된 어느 하나 이상인 것을 특징으로 하는, 제제.
- 제12항에 있어서, 상기 상전이 속도를 조절하는 고분자는 메틸 비닐 에테르 및 말레산 무수물의 공중합체인 것을 특징으로 하는 제제.
- 제8항에 있어서, 상기 제제는 암모늄 알지네이트(ammonium alginate), 마그네슘 알지네이트(magnesium alginate), 포타슘 알지네이트(potassium alginate), 소듐 알지네이트(sodium alginate), 리튬 알지네이트(lithium alginate) 또는 이의 혼합물 중에서 선택된 상전이 화합물; 및메틸 비닐 에테르 및 말레산 무수물의 공중합체(PVM/MA copolymer)를 포함하는 것을 특징으로 하는, 제제.
- 제8항에 있어서, 상기 제제는 제제의 총 중량 대비 0.01 중량% 내지 10 중량% 의 상전이 속도를 조절하는 고분자를 포함하는 것을 특징으로 하는 제제.
- 제8항에 있어서, 상기 제제에 포함된, 상전이 화합물과 상전이 속도를 조절하는 고분자의 혼합비율은상전이 화합물 : 상전이 속도를 조절하는 고분자가 5:0.01 내지 0.07의 중량비로 혼합되는 것을 특징으로 하는, 제제.
- 제8항에 있어서, 상기 제제는 15분 이내에 제제 내 함유된 약효성분의 70 중량% 이상이 제제에서 방출되는 것을 특징으로 하는 제제.
- 구강 내 전달을 위한 약효성분을 포함하고,알긴산 또는 이의 염; 및상기 알긴산 또는 이의 염과 혼합한 1분 후 제제의 경도가 140g 내지 350g이 되고, 10분 후 제제의 경도가 5,200g 내지 13,000g이 되는 고분자를 포함하며,상기 약효성분을 구강 내로 전달하는 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제18항에 있어서, 상기 제제는 알긴산 또는 이의 염과 메틸 비닐 에테르 및 말레산 무수물의 공중합체를 혼합하여 혼합 1분 후에 측정한 경도와 10분 후 측정한 경도의 차이가 5,000 g 내지 12,000g 인 것을 특징으로 하는 제제.
- 제18항에 있어서, 상기 알긴산 또는 이의 염과 혼합한 1분 후 제제의 경도가 140g 내지 350g이 되고, 10분 후 제제의 경도가 5,200g 내지 13,000g이 되는 고분자는 제제의 총 중량 대비 0.01 중량% 내지 10 중량% 포함되는 것을 특징으로 하는 제제.
- 제18항에 있어서, 상기 제제는 부착 후 15분 이내에 제제 내 함유된 약효성분의 70 중량% 이상이 제제에서 방출되는 것을 특징으로 하는 제제.
- 치아 또는 치아 주변부 부착용 제제에 있어서,상기 제제는 약효성분, 상전이 화합물, 및 수불용성이면서 에탄올에 용해되는 고분자를 포함하고, 상기 제제는 용제로 에탄올을 포함하며,상기 제제는 액상으로 치아 또는 치아 주변부에 도포되고, 구강 내 타액에 의해 상전이되어 치아 또는 치아 주변부에 부착성을 갖는, 치아 또는 치아 주변부 부착용 제제.
- 제22항에 있어서, 상기 상전이 화합물은 글리세릴 모노올레이트(glyceryl monooleate), 글리세릴 모노리놀레이트(glyceryl monolinoleate), 글리세릴 모노아라키도네이트(glyceryl monoarachidonate), 글리세릴 모노스테아레이트(glyceryl monostearate) 또는 이들의 혼합물 중에서 선택된 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제22항에 있어서, 상기 상전이 화합물은 상기 제제의 총 중량 대비 5 내지 80 중량% 포함되는 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제22항에 있어서, 상기 수불용성이면서 에탄올에 용해되는 고분자는, 에틸 셀룰로오즈, 피브이엠/엠에이코폴리머부틸에스터, 폴리비닐아세테이트, 폴리비닐아세테이트-프탈레이트, 쉘락, 로진, 메타아크릴산 공중합체, 또는 이의 혼합물인 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 수분과 접촉하기 전에는 10,000cPs 이하의 점성을 가지다가,치아 또는 구강 내에 도포된 후 치아 또는 구강 내 조직에 부착성을 갖는 겔 또는 고체로 상변이가 되는, 치아 또는 치아 주변부 부착용 제제.
- 제26항에 있어서, 상기 제제는, 수불용성이면서 에탄올에 용해되는 고분자 및 상전이 화합물을 포함하는 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제26항에 있어서, 상기 제제는 글리세릴 모노올레이트(glyceryl monooleate), 글리세릴 모노리놀레이트(glyceryl monolinoleate), 글리세릴 모노아라키도네이트(glyceryl monoarachidonate), 글리세릴 모노스테아레이트(glyceryl monostearate) 또는 이들의 혼합물 중에서 선택된 고분자; 및에틸 셀룰로오즈, 피브이엠/엠에이코폴리머부틸에스터, 폴리비닐아세테이트, 폴리비닐아세테이트-프탈레이트, 쉘락, 로진, 메타아크릴산 공중합체, 또는 이의 혼합물 중에서 선택된 고분자를, 모두 포함하는 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
- 제7항, 제8항, 제18항, 또는 제22항에 있어서, 상기 약효성분은 불화나트륨(sodium fluoride), 불화주석(stannous fluoride), 불화인듐(indium fluoride), 불화아민(amine fluoride), 일불화인산나트륨(sodium monofluorophosphate), 피로인산나트륨 (tetrasodium pyrophosphate, TSPP), 산성피로인산나트륨(sodium acid pyrophosphate, SAPP), 폴리인산나트륨(sodium tripolyphosphate, STP), 피로인산나트륨칼륨(sodium potassium pyrophosphate), 피로인산칼륨(tetrapotassium pyrophosphate), 산성 메타폴리인산나트륨(acidic sodium metaphosphate), 산성폴리인산나트륨(acidic sodium polyphosphate), 트리클로산(triclosan), 클로르헥시딘(chlorhexidine), 알렉시딘(alexidine), 헥세티딘(hexetidine), 산귀나린(sanguinarine), 염화벤잘코늄(benzalkonium chloride), 살리실아닐리드(salicylanilide), 브롬화도미펜(domiphen bromide), 염화세틸피리디늄(cetylpyridinium chloride, CPC), 염화테트라데실피리디늄(tetradecylpyridinium chloride, TPC), 아스피린(aspirin), 케토롤락(ketorolac), 플루비프로펜(flurbiprofen), 피록시캄(piroxicam), 메클로페남산(meclofenamic acid), 티아민(thiamine), 리보플라빈(riboflavin), 니코틴산(nicotinic acid), 판토텐산(pantothenic acid), 피리독신(pyridoxine), 바이오틴(biotin), 엽산(folic acid), 비타민 B12(vitamin B12), 리포산(lipoic acid), 아스코르빈산(ascorbic acid), 비타민 A(vitamin A), 비타민 D(vitamin D), 비타민 E(vitamin E), 비타민 K(vitamin K), 옥수수 불검화 정량 추출물, 후박 추출물, 몰약, 라타니아, 카모밀레, 폴리크레졸렌, 센텔라 정량 추출물, 육두구 추출물, 덱스판테놀(dexpanthenol), 베타-시토스테롤(β-sitosterol), 아세틸 살리실릭산(acetyl salicylic acid), 염화아연, 인산칼륨, 이인산칼륨, 염화칼슘, 옥살산, 옥살산 칼륨, 옥살산철(ferric oxalate), 또는 이들의 혼합물인 것을 특징으로 하는, 치아 또는 치아 주변부 부착용 제제.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201780006327.1A CN108472251B (zh) | 2016-01-13 | 2017-01-12 | 口腔用制剂 |
CN202210026652.7A CN114306214A (zh) | 2016-01-13 | 2017-01-12 | 口腔用制剂 |
JP2018536506A JP6882303B2 (ja) | 2016-01-13 | 2017-01-12 | 口腔用製剤 |
US16/069,325 US10925830B2 (en) | 2016-01-13 | 2017-01-12 | Preparation for oral cavity |
AU2017206470A AU2017206470B2 (en) | 2016-01-13 | 2017-01-12 | Preparation for oral cavity |
CN202210026648.0A CN114344249A (zh) | 2016-01-13 | 2017-01-12 | 口腔用制剂 |
EP17738649.7A EP3403644B1 (en) | 2016-01-13 | 2017-01-12 | Preparation for oral cavity |
US17/148,043 US11872310B2 (en) | 2016-01-13 | 2021-01-13 | Preparation for oral cavity |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160004353A KR102010417B1 (ko) | 2016-01-13 | 2016-01-13 | 구강용 제제 |
KR10-2016-0004353 | 2016-01-13 | ||
KR10-2016-0012964 | 2016-02-02 | ||
KR1020160012964A KR102089536B1 (ko) | 2016-02-02 | 2016-02-02 | 마우스밴드 |
KR1020160029820A KR102048372B1 (ko) | 2016-03-11 | 2016-03-11 | 구강용 제제 |
KR10-2016-0029820 | 2016-03-11 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/069,325 A-371-Of-International US10925830B2 (en) | 2016-01-13 | 2017-01-12 | Preparation for oral cavity |
US17/148,043 Division US11872310B2 (en) | 2016-01-13 | 2021-01-13 | Preparation for oral cavity |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2017123020A2 true WO2017123020A2 (ko) | 2017-07-20 |
WO2017123020A3 WO2017123020A3 (ko) | 2017-09-08 |
Family
ID=59312203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2017/000409 WO2017123020A2 (ko) | 2016-01-13 | 2017-01-12 | 구강용 제제 |
Country Status (7)
Country | Link |
---|---|
US (2) | US10925830B2 (ko) |
EP (1) | EP3403644B1 (ko) |
JP (3) | JP6882303B2 (ko) |
CN (3) | CN114306214A (ko) |
AU (1) | AU2017206470B2 (ko) |
TW (1) | TWI776797B (ko) |
WO (1) | WO2017123020A2 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021519343A (ja) * | 2018-03-22 | 2021-08-10 | ドテク−ソシエテ ア リスポンサビリタ リミタータ | ポリビニルアルコール及びポリ酸を含む、口腔疾患治療用の殺菌性及び/又は抗炎症性ゲル |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108289860A (zh) | 2015-11-24 | 2018-07-17 | 株式会社 Lg 生活健康 | 牙齿或者牙齿周边部粘贴用制剂 |
US10925830B2 (en) | 2016-01-13 | 2021-02-23 | Lg Household & Health Care Ltd. | Preparation for oral cavity |
CN109875903A (zh) * | 2018-12-17 | 2019-06-14 | 点铂医疗科技(常州)有限公司 | 一种亲水改性硅橡胶印模材料及其制备方法 |
CN112426403B (zh) * | 2020-12-09 | 2021-09-17 | 南京天纵易康生物科技股份有限公司 | 一种口腔溃疡凝胶及其制备方法和应用 |
CN113440424B (zh) * | 2021-07-30 | 2023-08-08 | 深圳爱尔创口腔技术有限公司 | 一种可同时护理牙齿和牙龈的牙贴及其制备方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4177900B2 (ja) | 1997-04-04 | 2008-11-05 | 株式会社クラレ | 歯周病治療用材料 |
US5989569A (en) | 1997-06-06 | 1999-11-23 | The Procter & Gamble Company | Delivery system for a tooth whitener using a permanently deformable strip of material |
US6682721B2 (en) * | 2000-03-17 | 2004-01-27 | Lg Household & Healthcare Ltd. | Patches for teeth whitening |
EP1284714B1 (en) * | 2000-03-23 | 2008-10-22 | Dentsply International, Inc. | Tooth whitening composition |
US6620405B2 (en) | 2001-11-01 | 2003-09-16 | 3M Innovative Properties Company | Delivery of hydrogel compositions as a fine mist |
JP4202656B2 (ja) * | 2002-02-19 | 2008-12-24 | サンスター株式会社 | 局所投与型徐放性軟膏 |
KR100550065B1 (ko) | 2002-07-24 | 2006-02-08 | 주식회사 태평양 | 하이드로젤 매트릭스 부착 치아 미백용 패취 |
JP5137286B2 (ja) | 2003-06-10 | 2013-02-06 | 帝國製薬株式会社 | フェンタニル含有口腔粘膜貼付剤 |
KR100623859B1 (ko) * | 2004-09-06 | 2006-09-19 | 주식회사 엘지생활건강 | 용시 겔화를 이용한 치아 미백 성분 전달 시스템 |
KR100657127B1 (ko) * | 2004-11-29 | 2006-12-12 | 주식회사 엘지생활건강 | 용시 겔화를 이용한 치아 미백 성분 전달 시스템 |
KR101065612B1 (ko) | 2005-02-25 | 2011-09-19 | 주식회사 엘지생활건강 | 속박성 건식 치아미백패취 |
KR100633682B1 (ko) * | 2005-03-18 | 2006-10-12 | 주식회사 엘지생활건강 | W/o 에멀젼 타입의 치아 미백제 |
US20080219935A1 (en) * | 2005-07-08 | 2008-09-11 | Sang-Hoon Kwak | Phase Transitive Breath Care Products |
BRPI0618828A2 (pt) * | 2005-11-22 | 2011-09-13 | Smithkline Beecham Corp | substrato de espuma e método para sua preparação |
KR100662203B1 (ko) * | 2005-12-05 | 2006-12-27 | 주식회사 엘지생활건강 | 용시 겔화를 이용한 치아 미백 성분 전달 시스템 |
WO2007066837A1 (en) * | 2005-12-06 | 2007-06-14 | Lg Household & Health Care Ltd. | Delivery system for tooth whitening component using in situ gelling |
KR100814250B1 (ko) | 2006-11-01 | 2008-03-17 | 주식회사 엘지생활건강 | 동시 용해 및 겔화 정제형 구강 위생 조성물 |
EP1986591A1 (en) | 2006-02-10 | 2008-11-05 | LG Household & Health Care Ltd. | In-situ melting and gelling tablet composition for oral care |
US20100303954A1 (en) * | 2007-05-25 | 2010-12-02 | Pere Ruiz Donaire | Chewing gum containing solution styrene butadiene random copolymer elastomer |
US8568697B2 (en) * | 2008-03-21 | 2013-10-29 | Colgate-Palmolive Company | High fluoride ion recovery compositions |
EP2416741B1 (en) * | 2009-04-06 | 2015-03-11 | Bender Analytical Holding B.V. | In situ gelling alginate systems |
CN102724963B (zh) * | 2009-10-05 | 2015-12-16 | 耶路撒冷希伯来大学伊萨姆研究开发公司 | 液体前体组合物及其用于口腔病的pH-依赖的缓释治疗的用途 |
JP5682264B2 (ja) * | 2010-11-30 | 2015-03-11 | ライオン株式会社 | 口腔用組成物及び歯周病原因菌の歯面付着抑制剤 |
US10076700B2 (en) * | 2013-06-21 | 2018-09-18 | Christopher W. Circo | Mouthguard |
KR102131272B1 (ko) * | 2014-03-26 | 2020-07-07 | 주식회사 엘지생활건강 | 치아용 패치의 부착성이 향상된 겔 조성물 |
US10925830B2 (en) | 2016-01-13 | 2021-02-23 | Lg Household & Health Care Ltd. | Preparation for oral cavity |
-
2017
- 2017-01-12 US US16/069,325 patent/US10925830B2/en active Active
- 2017-01-12 CN CN202210026652.7A patent/CN114306214A/zh active Pending
- 2017-01-12 EP EP17738649.7A patent/EP3403644B1/en active Active
- 2017-01-12 CN CN201780006327.1A patent/CN108472251B/zh active Active
- 2017-01-12 CN CN202210026648.0A patent/CN114344249A/zh active Pending
- 2017-01-12 AU AU2017206470A patent/AU2017206470B2/en active Active
- 2017-01-12 JP JP2018536506A patent/JP6882303B2/ja active Active
- 2017-01-12 WO PCT/KR2017/000409 patent/WO2017123020A2/ko active Application Filing
- 2017-01-13 TW TW106101310A patent/TWI776797B/zh active
-
2021
- 2021-01-13 US US17/148,043 patent/US11872310B2/en active Active
- 2021-04-30 JP JP2021077632A patent/JP7254854B2/ja active Active
-
2023
- 2023-03-29 JP JP2023053873A patent/JP2023073411A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021519343A (ja) * | 2018-03-22 | 2021-08-10 | ドテク−ソシエテ ア リスポンサビリタ リミタータ | ポリビニルアルコール及びポリ酸を含む、口腔疾患治療用の殺菌性及び/又は抗炎症性ゲル |
Also Published As
Publication number | Publication date |
---|---|
CN108472251B (zh) | 2022-02-01 |
EP3403644B1 (en) | 2024-03-06 |
TWI776797B (zh) | 2022-09-11 |
JP6882303B2 (ja) | 2021-06-02 |
JP2021107451A (ja) | 2021-07-29 |
TW201803597A (zh) | 2018-02-01 |
AU2017206470A1 (en) | 2018-08-30 |
JP2019501941A (ja) | 2019-01-24 |
US20210128464A1 (en) | 2021-05-06 |
CN114344249A (zh) | 2022-04-15 |
CN108472251A (zh) | 2018-08-31 |
EP3403644A2 (en) | 2018-11-21 |
WO2017123020A3 (ko) | 2017-09-08 |
EP3403644A4 (en) | 2019-12-04 |
US20190029955A1 (en) | 2019-01-31 |
AU2017206470B2 (en) | 2022-08-18 |
US11872310B2 (en) | 2024-01-16 |
JP2023073411A (ja) | 2023-05-25 |
US10925830B2 (en) | 2021-02-23 |
JP7254854B2 (ja) | 2023-04-10 |
CN114306214A (zh) | 2022-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017123020A2 (ko) | 구강용 제제 | |
WO2017090921A1 (ko) | 치아 또는 치아 주변부 부착용 제제 | |
WO2020197342A1 (ko) | 치약 조성물 | |
JPH0645536B2 (ja) | 口腔粘膜貼付剤および口腔粘膜貼付製剤 | |
WO2016167600A1 (ko) | 구강용 조성물 | |
US5593303A (en) | Attachment of orthodontic brackets | |
JPS6354318A (ja) | 口腔内製剤 | |
WO2019221513A1 (ko) | 신규한 브롬화 퓨라논 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물 | |
JP2005187330A (ja) | 歯牙貼布用製品及びゲル組成物の選定方法 | |
WO2017061699A1 (ko) | 칫솔질로 제거 가능한 치아 부착용 패치 | |
KR102010417B1 (ko) | 구강용 제제 | |
WO2012093774A2 (ko) | 포스포릴콜린 단위체를 함유하는 가교 공중합체 및 이를 포함하는 화장료 조성물 | |
US6593396B2 (en) | Denture adhesive | |
KR20170091988A (ko) | 마우스밴드 | |
WO2021125894A1 (ko) | 치아 부착용 패치 | |
KR101964840B1 (ko) | 가단성 구강 조성물을 포함하는 구강용 제제 | |
JPH08325128A (ja) | 口腔用長期滞留型基剤およびそれを用いた組成物 | |
KR20190093548A (ko) | 구강용 제제 | |
KR102361348B1 (ko) | 치아 또는 치아 주변부 부착용 제제 | |
WO2010006612A2 (en) | Canker sore patch | |
KR101510497B1 (ko) | 치아의 화장용 가압 전사 실 및 치면의 화장 방법 | |
JP2670495B2 (ja) | シアノアクリレート系歯髄覆罩材 | |
JPH01113054A (ja) | 口腔粘膜用貼付剤 | |
KR20040090061A (ko) | 치아 미백용 건조필름 및 그 제조방법 | |
WO2012091502A2 (ko) | 폴리사카라이드 기반의 그라프트 공중합체 및 이를 포함하는 퍼스날 케어용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17738649 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2018536506 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2017738649 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2017738649 Country of ref document: EP Effective date: 20180813 |
|
ENP | Entry into the national phase |
Ref document number: 2017206470 Country of ref document: AU Date of ref document: 20170112 Kind code of ref document: A |